[HTML] from nih.govJM Scheiman, PJ Devereaux, J Herlitz, PH Katelaris… - Heart, 2011 - ncbi.nlm.nih.gov This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in ...
A Sonnenberg - Gut, 2011 - gut.bmj.com The author's response: I appreciate the comments by Drs Johnson and Fitzsimmons.1 In my opinion, three separate issues need to be emphasised when trying to understand the long-term time trends of gastric cancer, gastric ulcer and duodenal ulcer as evidenced by their ... Related articles - All 2 versions
JM Scheiman, PJ Devereaux, J Herlitz, PH Katelaris… - Heart, 2011 - heart.bmj.com Objective To determine whether once-daily esomeprazole 40 mg or 20 mg compared with placebo reduces the incidence of peptic ulcers over 26 weeks of treatment in patients taking low-dose acetylsalicylic acid (ASA) and who are at risk for ulcer development. Cited by 2 - Related articles - All 4 versions
WH Chan, LW Khin, YFA Chung… - British Journal of …, 2011 - Wiley Online Library Rebleeding from peptic ulcers is a major contributor to death. This study compared standard (40-mg intravenous infusion of omeprazole once daily for 3 days) and high-dose (80-mg bolus of omeprazole followed by 8-mg/h infusion for 72 h) in reducing the rebleeding rate ... Related articles - All 3 versions
[PDF] from etrials.orgMA Rehman, IU Khan… - Journal of Postgraduate Medical …, 2011 - etrials.org CLINICAL FEATURES AND ENDOSCOPIC FINDINGS IN PEPTIC ULCER MUHAMMAD ABDUR RAHMAN. IKRAM ULLAH KHAN AND MOHAMMAD SADIQ SHAH Deporrrrient of' Medr'c:'ne, Pr;.rrgrrrdtrote Mcu'it'ul irrstititte. Lao'_r Rcotfirtg Hospt'ml'_ Pc.r.-'m't-vc:r'. ...